103 related articles for article (PubMed ID: 9315836)
41. Initial risk class and length of hospital stay in community-acquired pneumonia.
Menéndez R; Ferrando D; Vallés JM; Martínez E; Perpiñá M
Eur Respir J; 2001 Jul; 18(1):151-6. PubMed ID: 11510787
[TBL] [Abstract][Full Text] [Related]
42. Community-acquired pneumonia.
Niederman MS
Isr Med Assoc J; 2003 Feb; 5(2):133-8. PubMed ID: 12674669
[No Abstract] [Full Text] [Related]
43. Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.
Erard V; Lamy O; Bochud PY; Bille J; Cometta A; Calandra T
Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):82-8. PubMed ID: 14727149
[TBL] [Abstract][Full Text] [Related]
44. Antimicrobial treatment of community-acquired pneumonia in Hong Kong.
You JH; Lee VW; Au PS; Lee KK
Am J Health Syst Pharm; 2002 Sep; 59(18):1785-6. PubMed ID: 12298121
[No Abstract] [Full Text] [Related]
45. Role of gemifloxacin in community-acquired pneumonia.
Tillotson GS
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
[TBL] [Abstract][Full Text] [Related]
46. Therapy for severe community-acquired pneumonia.
Berk SL
Clin Infect Dis; 1997 Jul; 25(1):168-9. PubMed ID: 9243063
[No Abstract] [Full Text] [Related]
47. [Management of community-acquired pneumopathies of adults in the city and at the hospital].
Léophonte P
Presse Med; 1998 Sep; 27 Suppl 4():5-7. PubMed ID: 9798473
[No Abstract] [Full Text] [Related]
48. Comparative efficacy of sparfloxacin in comparison with amoxycillin plus ofloxacin in the treatment of community-acquired pneumonia. French Study Group.
Portier H; May T; Proust A
J Antimicrob Chemother; 1996 May; 37 Suppl A():83-91. PubMed ID: 8737128
[TBL] [Abstract][Full Text] [Related]
49. [Impact of the implementation of an intervention protocol in community-acquired pneumonia].
Ramírez-Montesinos R; Moreno-Arias CV; Carulla-Aresté M; Pedrol-Clotet E
Med Clin (Barc); 2012 Nov; 139(12):558-9. PubMed ID: 22698710
[No Abstract] [Full Text] [Related]
50. [The use of stepwise antibacterial therapy of community-acquired pneumonia].
Iashchenko AV; Sinopal'nikov AI
Klin Med (Mosk); 2014; 92(6):53-6. PubMed ID: 25799831
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
[TBL] [Abstract][Full Text] [Related]
52. [Antibiotic therapy of severe community-acquired pneumonia].
Molchanova OV; Suleĭmanov SSh; Ostrovskiĭ AB
Antibiot Khimioter; 2009; 54(3-4):29-31. PubMed ID: 19711847
[TBL] [Abstract][Full Text] [Related]
53. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.
Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM
Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825
[TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
Kohno S; Tateda K; Mikamo H; Kadota J; Niki Y; Itamura R
J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
[TBL] [Abstract][Full Text] [Related]
55. Impact of guidelines on outcome: the evidence.
Martínez R; Reyes S; Lorenzo MJ; Menéndez R
Semin Respir Crit Care Med; 2009 Apr; 30(2):172-8. PubMed ID: 19296417
[TBL] [Abstract][Full Text] [Related]
56. [Can aminopenicillin be prescribed as monotherapy in case of community-acquired pneumonia?].
Léophonte P
Presse Med; 1998 Oct; 27(31):1580-1. PubMed ID: 9819592
[TBL] [Abstract][Full Text] [Related]
57. [Risk classification in community-acquired pneumonia].
Pommer P
Internist (Berl); 2006 May; 47(5):545; author reply 545. PubMed ID: 17415896
[No Abstract] [Full Text] [Related]
58. Adult response to initial treatment with ampicillin in community acquired pneumonia in Yaoundé, Cameroon.
Koulla-Shiro S; Kuaban C; Auckenthaler R; Belec L; Ngu JL
Cent Afr J Med; 1993 Sep; 39(9):188-92. PubMed ID: 8020088
[TBL] [Abstract][Full Text] [Related]
59. Ampicillin/sulbactam for children hospitalized with community-acquired pneumonia.
Tapısız A; Özdemir H; Çiftçi E; Belet N; Ince E; Doğru Ü
J Infect Chemother; 2011 Aug; 17(4):504-9. PubMed ID: 21258955
[TBL] [Abstract][Full Text] [Related]
60. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
